Frontend Software Development Engineer at IQVIA

Compensation

$160,000 – $242,550/yr

Setup: Remote, Hybrid
Location: Warsaw, Masovian Voivodeship
Type: Full-time

Description

IQVIA is seeking a Frontend Software Development Engineer to design, build, and optimize user-centric web interfaces within enterprise digital platforms. This role involves close collaboration with designers, backend teams, and product stakeholders to deliver high-performing, responsive, and accessible web applications across CMS and LMS environments. The ideal candidate will have strong expertise in modern JavaScript frameworks like React, Vue.js, or Angular, with a preference for Drupal experience.

Required Skills

HTML5
CSS3 (SASS/LESS)
JavaScript (ES6+)
React
Vue.js
Angular
Drupal
Opigno LMS
Acquia
JIRA
PHP
Python
Java
.NET
MySQL
PostgreSQL
SQL Server

Additional Information

Minimum Education: Degree in Computer Science (or equivalent experience)
Required Previous Experiences: Proven experience in frontend web development, ideally within complex or enterprise environments
Strong expertise in modern JavaScript frameworks (React, Vue, or Angular)
Experience working with CMS-driven platforms, especially Drupal
Experience working in Agile environments with cross-functional teams

About IQVIA

IQVIA

Life Sciences

<h3>Your way further</h3> <p>Data and information is expanding by the minute and demand analytics that can keep the pace.</p> <p>IQVIA is inspired by the pace of change in healthcare. Our collective understanding of human health and the science of disease is deepening. Data and information is expanding by the minute, and demanding analytics that can keep up. Technologies are emerging and transforming the way we ask questions, find solutions and make decisions.</p> <p>We are also committed to harnessing and accelerating change, and creating real, actionable insights that modernize how drugs are developed and brought to market. Our driving goal is to help customers better understand this data so they are able to elevate value and outcomes for patients.  </p>